ArticleCureus2026
Historical Trends in Intraocular Lens Innovation Through an Analysis of United States Patents, 1972-2000.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the great advancements in ophthalmic surgery during the 20th century was the development of the artificial intraocular lens (IOL). There is remarkably little historical information on the trends in IOL innovation based on what inventors believed was worthy of patent protection in the United States (U.S.). We explored the topic of patentable IOL innovations by obtaining information through a global patent database. Patents issued for IOLs in the U.S. during the 20th century were identified. A total of 583 IOL patents were issued in the U.S. last century. Based on creators' justification of "unique" innovation, the single largest patentable category was lens design (264 (45.3%)), of which 197 (74.6%) were related to haptics. Time trends in some patent categories overlapped with the rise of phacoemulsification surgery. Just over half of the patents were owned by corporations (302 (51.8%)), while 254 (43.6%) were owned by individuals and 27 (4.6%) were owned by universities. Novel innovations in IOLs in the U.S. reached a peak during the last two decades of the 20th century. Individuals owned a disproportionately high number of patents compared with other technology sectors. Only 156 patents (30.7%) were maintained throughout the full 20-year term. The authors speculate that the high rate of patent abandonment reflects a high rate of competing innovations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.